New study aims to catch nerve damage early in chemo patients
NCT ID NCT07095998
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how nerves are affected in people who develop nerve damage from the chemotherapy drug cisplatin. Researchers will use a special test to measure nerve activity and compare it to normal nerves. The goal is to better understand this side effect and find early warning signs. The study involves 60 adults starting cisplatin treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute
NOT_YET_RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
- Wearable insoles warn of foot pressure to stop diabetic ulcers
- New bladder cancer drug aims to fight tumors without harming nerves
- Acupuncture with a jolt: could needles shield nerves from chemo?
- Could your own stem cells heal your brain? new trial tests it
- Acupuncture needles aim to stop Chemo's nerve pain